Clinical Trial: The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina Pectoris
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Vasospastic Angina
Study Type: INTERVENTIONAL
Official Title: Vericiguat in Vasospastic Angina
Brief Summary:
Vasospastic angina is increasingly recognized as an important contributor to anginal symptoms in patients with non-obstructive coronary artery disease (ANOCA). Endothelial dysfunction and smooth muscle cell dysfunction are considered elementary in the development of vasospastic angina. As one of many functions, the vascular endothelium regulates local vascular tone, mainly through the vasodilatory effect of endothelium-derived nitric oxide (NO). Vericiguat is a soluble guanylate cyclase (sGC) stimulator and…
Read more